Cargando…

Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach

INTRODUCTION: The increasing burden of dengue fever (DF) in the Americas, and the current epidemic in previously unaffected countries, generate major costs for national healthcare systems. There is a need to quantify the average cost per DF case. In Mexico, few data are available on costs, despite D...

Descripción completa

Detalles Bibliográficos
Autores principales: Zubieta-Zavala, Adriana, Salinas-Escudero, Guillermo, Ramírez-Chávez, Adrian, García-Valladares, Luis, López-Cervantes, Malaquias, López Yescas, Juan Guillermo, Durán-Arenas, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976855/
https://www.ncbi.nlm.nih.gov/pubmed/27501146
http://dx.doi.org/10.1371/journal.pntd.0004897
_version_ 1782446926881357824
author Zubieta-Zavala, Adriana
Salinas-Escudero, Guillermo
Ramírez-Chávez, Adrian
García-Valladares, Luis
López-Cervantes, Malaquias
López Yescas, Juan Guillermo
Durán-Arenas, Luis
author_facet Zubieta-Zavala, Adriana
Salinas-Escudero, Guillermo
Ramírez-Chávez, Adrian
García-Valladares, Luis
López-Cervantes, Malaquias
López Yescas, Juan Guillermo
Durán-Arenas, Luis
author_sort Zubieta-Zavala, Adriana
collection PubMed
description INTRODUCTION: The increasing burden of dengue fever (DF) in the Americas, and the current epidemic in previously unaffected countries, generate major costs for national healthcare systems. There is a need to quantify the average cost per DF case. In Mexico, few data are available on costs, despite DF being endemic in some areas. Extrapolations from studies in other countries may prove unreliable and are complicated by the two main Mexican healthcare systems (the Secretariat of Health [SS] and the Mexican Social Security Institute [IMSS]). The present study aimed to generate specific average DF cost-per-case data for Mexico using a micro-costing approach. METHODS: Expected medical costs associated with an ideal management protocol for DF (denoted ´ideal costs´) were compared with the medical costs of current treatment practice (denoted ´real costs´) in 2012. Real cost data were derived from chart review of DF cases and interviews with patients and key personnel from 64 selected hospitals and ambulatory care units in 16 states for IMSS and SS. In both institutions, ideal and real costs were estimated using the program, actions, activities, tasks, inputs (PAATI) approach, a micro-costing technique developed by us. RESULTS: Clinical pathways were obtained for 1,168 patients following review of 1,293 charts. Ideal and real costs for SS patients were US$165.72 and US$32.60, respectively, in the outpatient setting, and US$587.77 and US$490.93, respectively, in the hospital setting. For IMSS patients, ideal and real costs were US$337.50 and US$92.03, respectively, in the outpatient setting, and US$2,042.54 and US$1,644.69 in the hospital setting. CONCLUSIONS: The markedly higher ideal versus real costs may indicate deficiencies in the actual care of patients with DF. It may be necessary to derive better estimates with micro-costing techniques and compare the ideal protocol with current practice when calculating these costs, as patients do not always receive optimal care.
format Online
Article
Text
id pubmed-4976855
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49768552016-08-25 Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach Zubieta-Zavala, Adriana Salinas-Escudero, Guillermo Ramírez-Chávez, Adrian García-Valladares, Luis López-Cervantes, Malaquias López Yescas, Juan Guillermo Durán-Arenas, Luis PLoS Negl Trop Dis Research Article INTRODUCTION: The increasing burden of dengue fever (DF) in the Americas, and the current epidemic in previously unaffected countries, generate major costs for national healthcare systems. There is a need to quantify the average cost per DF case. In Mexico, few data are available on costs, despite DF being endemic in some areas. Extrapolations from studies in other countries may prove unreliable and are complicated by the two main Mexican healthcare systems (the Secretariat of Health [SS] and the Mexican Social Security Institute [IMSS]). The present study aimed to generate specific average DF cost-per-case data for Mexico using a micro-costing approach. METHODS: Expected medical costs associated with an ideal management protocol for DF (denoted ´ideal costs´) were compared with the medical costs of current treatment practice (denoted ´real costs´) in 2012. Real cost data were derived from chart review of DF cases and interviews with patients and key personnel from 64 selected hospitals and ambulatory care units in 16 states for IMSS and SS. In both institutions, ideal and real costs were estimated using the program, actions, activities, tasks, inputs (PAATI) approach, a micro-costing technique developed by us. RESULTS: Clinical pathways were obtained for 1,168 patients following review of 1,293 charts. Ideal and real costs for SS patients were US$165.72 and US$32.60, respectively, in the outpatient setting, and US$587.77 and US$490.93, respectively, in the hospital setting. For IMSS patients, ideal and real costs were US$337.50 and US$92.03, respectively, in the outpatient setting, and US$2,042.54 and US$1,644.69 in the hospital setting. CONCLUSIONS: The markedly higher ideal versus real costs may indicate deficiencies in the actual care of patients with DF. It may be necessary to derive better estimates with micro-costing techniques and compare the ideal protocol with current practice when calculating these costs, as patients do not always receive optimal care. Public Library of Science 2016-08-08 /pmc/articles/PMC4976855/ /pubmed/27501146 http://dx.doi.org/10.1371/journal.pntd.0004897 Text en © 2016 Zubieta-Zavala et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Zubieta-Zavala, Adriana
Salinas-Escudero, Guillermo
Ramírez-Chávez, Adrian
García-Valladares, Luis
López-Cervantes, Malaquias
López Yescas, Juan Guillermo
Durán-Arenas, Luis
Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach
title Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach
title_full Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach
title_fullStr Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach
title_full_unstemmed Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach
title_short Calculation of the Average Cost per Case of Dengue Fever in Mexico Using a Micro-Costing Approach
title_sort calculation of the average cost per case of dengue fever in mexico using a micro-costing approach
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976855/
https://www.ncbi.nlm.nih.gov/pubmed/27501146
http://dx.doi.org/10.1371/journal.pntd.0004897
work_keys_str_mv AT zubietazavalaadriana calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach
AT salinasescuderoguillermo calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach
AT ramirezchavezadrian calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach
AT garciavalladaresluis calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach
AT lopezcervantesmalaquias calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach
AT lopezyescasjuanguillermo calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach
AT duranarenasluis calculationoftheaveragecostpercaseofdenguefeverinmexicousingamicrocostingapproach